Home | Welcome to Contract Pharma   
Last Updated Saturday, October 25 2014
Print

BioFocus Adds Senior Director



By Gil Roth



Published February 11, 2013
Related Searches: CRO Development
Dr. Peter Rehse has been named senior director, Structural Biology at BioFocus. He will be based at Chesterford Park, near Cambridge, UK. His responsibilities will include managing the structural biology and fragment-based screening groups within the Biological Sciences division.

Dr. Rehse has joined the company from the Chinese CRO Shanghai Medicilon Inc., where, as vice president, he was responsible for the strategic business and scientific development of the structural biology and structure-based drug design unit. Prior to this, he worked at RIKEN Harima Institute in Japan and has held several academic positions in Japan and Canada.  

“With Peter’s international credibility we will be able to strengthen and grow our structural biology and fragment screening operation,” commented Dr. Kate Hilyard, vice president Biological Sciences, BioFocus. “This hire reflects our ongoing commitment to accelerate our client’s discovery programs through investing in the right people."


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On